Montgomery Investment Management’s Pfizer PFE Stock Holding History

Montgomery Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$421K	Hold	17,470	–	–	0.13%	83
2026 Q1	$491K	Hold	17,470	–	–	0.17%	74
2025 Q4	$435K	Hold	17,470	–	–	0.16%	75
2025 Q3	$445K	Sell	17,470 -231	-1%	-$5.7K	0.16%	74
2025 Q2	$429K	Sell	17,701 -800	-4%	-$18.7K	0.17%	69
2025 Q1	$469K	Sell	18,501 -501	-3%	-$13.1K	0.19%	63
2024 Q4	$504K	Sell	19,002 -300	-2%	-$8.14K	0.2%	61
2024 Q3	$559K	Hold	19,302	–	–	0.2%	56
2024 Q2	$540K	Hold	19,302	–	–	0.21%	54
2024 Q1	$536K	Sell	19,302 -9,900	-34%	-$275K	0.2%	54
2023 Q4	$841K	Hold	29,202	–	–	0.26%	49
2023 Q3	$969K	Hold	29,202	–	–	0.33%	43
2023 Q2	$1.07M	Sell	29,202 -1,000	-3%	-$38.9K	0.36%	42
2023 Q1	$1.23M	Sell	30,202 -30	-0.1%	-$1.3K	0.44%	41
2022 Q4	$1.55M	Hold	30,232	–	–	0.55%	38
2022 Q3	$1.32M	Buy	30,232 +2,970	+11%	+$144K	0.54%	40
2022 Q2	$1.43M	Buy	27,262 +1,300	+5%	+$66.2K	0.58%	39
2022 Q1	$1.34M	Buy	25,962 +2,700	+12%	+$140K	0.46%	41
2021 Q4	$1.37M	Buy	23,262 +5,200	+29%	+$258K	0.46%	40
2021 Q3	$777K	Hold	18,062	–	–	0.29%	51
2021 Q2	$708K	Sell	18,062 -800	-4%	-$31.1K	0.26%	53
2021 Q1	$684K	Buy	18,862 +2,200	+13%	+$78.1K	0.26%	51
2020 Q4	$614K	Sell	16,662 -373	-2%	-$13.7K	0.28%	51
2020 Q3	$593K	Sell	17,035 -948	-5%	-$33.2K	0.31%	48
2020 Q2	$558K	Sell	17,983 -1,054	-6%	-$35.8K	0.3%	52
2020 Q1	$589K	Hold	19,037	–	–	0.38%	47
2019 Q4	$708K	Sell	19,037 -949	-5%	-$33.8K	0.29%	58
2019 Q3	$681K	Hold	19,986	–	–	0.29%	59
2019 Q2	$821K	Hold	19,986	–	–	0.36%	49
2019 Q1	$806K	Hold	19,986	–	–	0.36%	54
2018 Q4	$828K	Hold	19,986	–	–	0.42%	49
2018 Q3	$836K	Hold	19,986	–	–	0.34%	56
2018 Q2	$688K	Hold	19,986	–	–	0.28%	55
2018 Q1	$673K	Hold	19,986	–	–	0.28%	53
2017 Q4	$687K	Hold	19,986	–	–	0.28%	55
2017 Q3	$677K	Hold	19,986	–	–	0.3%	56
2017 Q2	$637K	Hold	19,986	–	–	0.29%	56
2017 Q1	$649K	Hold	19,986	–	–	0.28%	58
2016 Q4	$616K	Hold	19,986	–	–	0.26%	60
2016 Q3	$642K	Buy	19,986 +843	+4%	+$28.2K	0.3%	59
2016 Q2	$639K	Sell	19,143 -1,792	-9%	-$57.2K	0.31%	58
2016 Q1	$588K	Sell	20,935 -1,159	-5%	-$33.1K	0.34%	53
2015 Q4	$677K	Hold	22,094	–	–	0.38%	52
2015 Q3	$658K	Hold	22,094	–	–	0.39%	52
2015 Q2	$703K	Sell	22,094 -1,686	-7%	-$54.9K	0.36%	56
2015 Q1	$785K	Hold	23,780	–	–	0.39%	54
2014 Q4	$702K	Buy	23,780 +10,856	+84%	+$311K	0.34%	56
2014 Q3	$363K	Sell	12,924 -3,215	-20%	-$90.2K	0.25%	60
2014 Q2	$454K	Sell	16,139 -3,909	-19%	-$111K	0.35%	54
2014 Q1	$611K	Sell	20,048 -1,739	-8%	-$51.9K	0.5%	50
2013 Q4	$633K	Sell	21,787 -29,144	-57%	-$848K	0.52%	48
2013 Q3	$1.39M	Buy	50,931 +685	+1%	+$18.6K	0.76%	39
2013 Q2	$1.33M	Buy	+50,246	New	+$1.39M	0.73%	40

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Montgomery Investment Management's PFE Position: Q2 2026 in Review

Montgomery Investment Management held its Pfizer (PFE) position steady in Q2 2026 at 17,470 shares worth $421K. The position accounts for 0.13% of the portfolio, ranked #83.

Montgomery Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.55M in Q4 2022. 489 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Montgomery Investment Management held 17,470 shares of Pfizer worth $421K as of Q2 2026.
Montgomery Investment Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.13% of Montgomery Investment Management's portfolio in Q2 2026, its #83 holding.
Montgomery Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Montgomery Investment Management's Pfizer position peaked at $1.55M in Q4 2022.
489 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Montgomery Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.